CITADEL ADVISORS LLC

Position in MTNB — Matinas BioPharma Holdings, Inc.

CIK 1423053 MIAMI, FL

Position in MTNB

as of Jun 30, 2026 · filed Sep 2, 2026 Compact

Position Value

$9,464

-$16,385 QoQ

Shares Held

15,465

-70.1% QoQ

Ownership

0.105%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 25 holders

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,758,606 across 435 Biotechnology names. MTNB ranks #425 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ONC	BeOne Medicines Ltd.	1,425,517	$406,229,578
2	BBIO	BridgeBio Pharma, Inc.	3,760,028	$280,046,885
3	INSM	INSMED Inc	2,556,973	$272,624,460
4	MDGL	Madrigal Pharmaceuticals, Inc.	507,233	$272,358,759
5	VRTX	Vertex Pharmaceuticals Inc / Ma	510,430	$253,545,893
6	JAZZ	Jazz Pharmaceuticals plc	1,006,676	$242,578,715
7	MANE	Veradermics, Inc	1,877,775	$230,853,658
8	ROIV	Roivant Sciences Ltd.	5,576,261	$197,343,876

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,464	15,465	-70.1%	Shares	Defined	2026-09-02
2026-03-31	$25,849	51,698	-21.4%	Shares	Defined	2026-05-15
2025-12-31	$38,520	65,734	+26.2%	Shares	Defined	2026-02-17
2022-12-31	$26,053	52,106	+150.5%	Shares	Defined	2023-02-14
2022-09-30	$13,229	20,801	-82.4%	Shares	Defined	2022-11-14
2021-12-31	$119,219	118,039	-36.1%	Shares	Defined	2022-02-14
2021-09-30	$240,323	184,865	-41.3%	Shares	Defined	2021-11-15
2021-03-31	$330,449	314,715	+194.2%	Shares	Defined	2021-05-21
2020-12-31	$145,468	106,962	+45.6%	Shares	Defined	2021-02-16
2020-09-30	$56,254	73,439	-37.1%	Shares	Defined	2020-11-16
2020-06-30	$90,318	116,841	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.